New patent for Pfizer drug VIZIMPRO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for VIZIMPRO
Annual Drug Patent Expirations for VIZIMPRO

Vizimpro is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.

This drug has fifty-one patent family members in forty-five countries.

The generic ingredient in VIZIMPRO is dacomitinib. Two suppliers are listed for this compound. Additional details are available on the dacomitinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top